Shares of Hikma Pharmaceuticals PLC HIK rallied 1.64% to £18.01 Thursday, on what proved to be an all-around poor trading ...
Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...
Schizophrenia significantly shortens life expectancy by an estimated 15 years with excess mortality arising from multiple ...
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading.
The company also reiterated guidance for its Branded business of revenue in the high-single digits, or 6% to 8% higher year-on-year, with a core operating margin around 25%. Its Generics business is ...
Hikma Pharmaceuticals PLC HIK shares shed 1.94% to £18.20 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.14% to ...
Hikma Pharmaceuticals reiterated its full-year outlook on Thursday on the back of strong trading across the business.
Hikma Pharmaceuticals updated the market over the significant opposition to a resolution at its annual general meeting on ...
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Tuesday .The stock has a two hundred day moving average of ...
US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...
(Sharecast News) - Hikma Pharmaceuticals updated the market over the significant opposition to a resolution at its annual general meeting on Thursday. The FTSE 100 company said the resolution ...
General Anesthesia Drugs MarketThe global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate ...